TCM
CRL icon

TimesSquare Capital Management’s Charles River Laboratories CRL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-129,208
Closed -$26.7M 159
2024
Q2
$26.7M Sell
129,208
-5,795
-4% -$1.2M 0.42% 96
2024
Q1
$36.6M Buy
135,003
+103,168
+324% +$28M 0.53% 75
2023
Q4
$7.53M Buy
+31,835
New +$7.53M 0.11% 143
2023
Q1
Sell
-29,900
Closed -$6.52M 183
2022
Q4
$6.52M Sell
29,900
-7,104
-19% -$1.55M 0.09% 157
2022
Q3
$7.28M Sell
37,004
-201,200
-84% -$39.6M 0.1% 161
2022
Q2
$51M Sell
238,204
-83,750
-26% -$17.9M 0.71% 52
2022
Q1
$91.4M Sell
321,954
-57,250
-15% -$16.3M 1.03% 15
2021
Q4
$143M Buy
379,204
+3,104
+0.8% +$1.17M 1.27% 9
2021
Q3
$155M Sell
376,100
-124,600
-25% -$51.4M 1.35% 4
2021
Q2
$185M Sell
500,700
-93,050
-16% -$34.4M 1.52% 5
2021
Q1
$172M Sell
593,750
-215,300
-27% -$62.4M 1.47% 2
2020
Q4
$202M Buy
809,050
+195,375
+32% +$48.8M 1.64% 2
2020
Q3
$139M Sell
613,675
-30,135
-5% -$6.82M 1.3% 4
2020
Q2
$112M Sell
643,810
-90,040
-12% -$15.7M 1.07% 10
2020
Q1
$92.6M Sell
733,850
-59,925
-8% -$7.56M 1.1% 10
2019
Q4
$121M Sell
793,775
-213,975
-21% -$32.7M 1.08% 8
2019
Q3
$133M Buy
1,007,750
+99,900
+11% +$13.2M 1.18% 7
2019
Q2
$129M Buy
907,850
+44,275
+5% +$6.28M 0.99% 20
2019
Q1
$125M Sell
863,575
-163,475
-16% -$23.7M 0.97% 20
2018
Q4
$116M Sell
1,027,050
-135,125
-12% -$15.3M 1% 17
2018
Q3
$156M Buy
1,162,175
+152,505
+15% +$20.5M 1.04% 15
2018
Q2
$113M Buy
1,009,670
+149,550
+17% +$16.8M 0.76% 31
2018
Q1
$91.8M Sell
860,120
-55,480
-6% -$5.92M 0.62% 45
2017
Q4
$100M Buy
915,600
+589,900
+181% +$64.6M 0.66% 45
2017
Q3
$35.2M Buy
+325,700
New +$35.2M 0.24% 157